DRUG POLICY ALLIANCE

Lobbying client · New York · filed 2025 to 2026

$82,977 Reported spend

6 Filings counted

1 Firms hired

15 Bills named

Spend is reported income plus in-house expenses across 6 filings. Everything on this page is grouped by the client's LDA id (164176), not by name.

Firms hired 1

DRUG POLICY ALLIANCE $82,977 6 filings

Bills named in these filings 15

HR 9694
Fair Future Act

4 filings
S 5111
Fair Future Act

4 filings
HR 3479
RESTORE Act of 2023

3 filings
HR 5601
MORE Act

3 filings
S 1753
RESTORE Act of 2023

3 filings
HR 5068
MORE Act

3 filings
HR 5223
RESTORE Act of 2025

3 filings
HR 1266
Combating Illicit Xylazine Act

2 filings
HR 27
HALT Fentanyl Act

2 filings
HR 5415
Nitazene Control Act of 2025

2 filings
HR 7765
Fair Future Act

2 filings
HR 7970
STOP Nitazenes Act

2 filings
S 3076
Nitazene Control Act

2 filings
S 331
HALT Fentanyl Act

2 filings
S 545
Combating Illicit Xylazine Act

2 filings

Reported by year 2 years

2026 $18,639 2 filings
2025 $64,338 4 filings

Issues lobbied 3

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Recent filings 6 total

Q2

DRUG POLICY ALLIANCE

2nd Quarter (Apr 1 - June 30) 2026 · $18,639 expenses · posted Jul 17, 2026

View → Q1

DRUG POLICY ALLIANCE

1st Quarter (Jan 1 - Mar 31) 2026 · posted Apr 19, 2026

View → Q4

DRUG POLICY ALLIANCE

4th Quarter (Oct 1 - Dec 31) 2025 · $7,971 expenses · posted Jan 18, 2026

View → Q3

DRUG POLICY ALLIANCE

3rd Quarter (July 1 - Sep 30) 2025 · $25,000 expenses · posted Oct 18, 2025

View → Q2

DRUG POLICY ALLIANCE

2nd Quarter (Apr 1 - June 30) 2025 · $21,013 expenses · posted Jul 21, 2025

View → Q1

DRUG POLICY ALLIANCE

1st Quarter (Jan 1 - Mar 31) 2025 · $10,353 expenses · posted Apr 20, 2025

View →

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.